Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Hepatocellular 5Stomach Neoplasms 4Advanced Gastric Cancer 3Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Small Cell Lung Carcinoma 1Respiratory Tract Diseases 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroblastoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Lung Diseases 1Locally Advanced or Metastatic Gastric Adenocarcinoma 1Liver Neoplasms 1Hepatic Metastasis of Colorectal Cancer 1Head and Neck Neoplasms 1Glioma 1Colorectal Neoplasms 1Colorectal Cancer Recurrent 1Biliary Tract Neoplasms 1Advanced Triple Negative Breast Cancer 1Advanced Solid Tumors 1

Interventions

Temozolomide 26Radiotherapy 10Bevacizumab 10Carboplatin 6Irinotecan 5pembrolizumab 4Radiation 4Nivolumab 4IL13-PE38 4temsirolimus 3Surgical Procedures, Operative 3Magnetic Resonance Spectroscopy 3Immunotherapy, Adoptive 3Erlotinib Hydrochloride 3Aminolevulinic Acid 3trametinib 2olaparib 2lutetium Lu 177 dotatate 2fludarabine 2dabrafenib 2cemiplimab 2abemaciclib 2Vorinostat 2Transurethral Resection of Bladder 2Sirolimus 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Imatinib Mesylate 2Flucytosine 2Cyclophosphamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Glioma × apatinib × Clear all
NCT02848794 2017-06-16

Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma

The First People's Hospital of Lianyungang

Phase 1/2 Unknown
40 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡